Osteochondrodysplasia
Showing 1 - 5 of 5
Osteochondrodysplasia Trial in Parkville (SAR442501)
Recruiting
- Osteochondrodysplasia
-
Parkville, Victoria, AustraliaInvestigational Site Number: 0360001
Oct 10, 2023
Osteochondrodysplasia Trial in Newark (SAR442501, Placebo)
Completed
- Osteochondrodysplasia
- SAR442501
- Placebo
-
Newark, New JerseyInvestigational site
Apr 26, 2023
Children With Achondroplasia (ACH)
Recruiting
- Achondroplasia
-
Oakland, California
- +19 more
Apr 6, 2022
Achondroplasia Trial in Worldwide (Infigratinib 0.016 mg/kg, Infigratinib 0.032 mg/kg, Infigratinib 0.064 mg/kg)
Recruiting
- Achondroplasia
- Infigratinib 0.016 mg/kg
- +3 more
-
Oakland, California
- +17 more
Apr 5, 2022